Does ROSUVASTATIN Cause Hyperlipidaemia? 179 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 179 reports of Hyperlipidaemia have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.5% of all adverse event reports for ROSUVASTATIN.
179
Reports of Hyperlipidaemia with ROSUVASTATIN
0.5%
of all ROSUVASTATIN reports
12
Deaths
93
Hospitalizations
How Dangerous Is Hyperlipidaemia From ROSUVASTATIN?
Of the 179 reports, 12 (6.7%) resulted in death, 93 (52.0%) required hospitalization, and 9 (5.0%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 179 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
METOPROLOL (138)
Which ROSUVASTATIN Alternatives Have Lower Hyperlipidaemia Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN